RT Journal Article SR Electronic T1 Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.07.28.20164038 DO 10.1101/2020.07.28.20164038 A1 Christina M. Newman A1 Dawn M. Dudley A1 Roger W. Wiseman A1 Matthew T. McLaughlin A1 Julie A. Karl A1 Miranda R. Stauss A1 Andrea M. Weiler A1 Mason I. Bliss A1 Mitchell D. Ramuta A1 Cecilia G. Shortreed A1 Amelia K. Haj A1 Anna S. Heffron A1 Matthew R. Reynolds A1 Katrina N. Fauser A1 Corrie B. Burmeister A1 Kristi L. Hall A1 Thomas C. Friedrich A1 Shelby L. O’Connor A1 David H. O’Connor YR 2020 UL http://medrxiv.org/content/early/2020/08/05/2020.07.28.20164038.abstract AB SARS-CoV-2 control in the United States is hampered by limited testing. We evaluated a simple, outdoor, mobile RT-LAMP assay workflow where self-collected saliva is tested for SARS-CoV-2 RNA. 494 volunteers were tested over 16 days. Testing results were 99.8% concordant with qRT-PCR, with all but two people testing SARS-CoV-2-negative.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was made possible by financial support through NIH Rapid Acceleration of Diagnostics (contract number pending). Additional funding was provided by both Wisconsin National Primate Research Center (WNPRC) and from Wisconsin Alumni Research Foundation COVID-19 Challenge.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was performed under approved UW-Madison Health Sciences IRB Protocol #2020-0855.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and protocols are available at https://openresearch.labkey.com/wiki/Coven/page.view?name=field-testing